These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 33122438)

  • 1. It is unclear how important CRISPR-Cas systems are for protecting natural populations of bacteria against infections by mobile genetic elements.
    Westra ER; Levin BR
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):27777-27785. PubMed ID: 33122438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas in mobile genetic elements: counter-defence and beyond.
    Faure G; Shmakov SA; Yan WX; Cheng DR; Scott DA; Peters JE; Makarova KS; Koonin EV
    Nat Rev Microbiol; 2019 Aug; 17(8):513-525. PubMed ID: 31165781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral diversity threshold for adaptive immunity in prokaryotes.
    Weinberger AD; Wolf YI; Lobkovsky AE; Gilmore MS; Koonin EV
    mBio; 2012 Dec; 3(6):e00456-12. PubMed ID: 23221803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
    Hwang S; Maxwell KL
    CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas systems and RNA-guided interference.
    Barrangou R
    Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids.
    Jiang W; Maniv I; Arain F; Wang Y; Levin BR; Marraffini LA
    PLoS Genet; 2013; 9(9):e1003844. PubMed ID: 24086164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CRISPR-Cas systems by mobile genetic elements.
    Sontheimer EJ; Davidson AR
    Curr Opin Microbiol; 2017 Jun; 37():120-127. PubMed ID: 28668720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Why so rare if so essentiel: the determinants of the sparse distribution of CRISPR-Cas systems in bacterial genomes].
    Bernheim A
    Biol Aujourdhui; 2017; 211(4):255-264. PubMed ID: 29956652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence of inhibition of horizontal gene transfer by CRISPR-Cas on evolutionary timescales.
    Gophna U; Kristensen DM; Wolf YI; Popa O; Drevet C; Koonin EV
    ISME J; 2015 Sep; 9(9):2021-7. PubMed ID: 25710183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CRISPR-Cas Immune System and Genetic Transfers: Reaching an Equilibrium.
    Samson JE; Magadan AH; Moineau S
    Microbiol Spectr; 2015 Feb; 3(1):PLAS-0034-2014. PubMed ID: 26104549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems.
    Mohanraju P; Makarova KS; Zetsche B; Zhang F; Koonin EV; van der Oost J
    Science; 2016 Aug; 353(6299):aad5147. PubMed ID: 27493190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas-Mediated Phage Resistance Enhances Horizontal Gene Transfer by Transduction.
    Watson BNJ; Staals RHJ; Fineran PC
    mBio; 2018 Feb; 9(1):. PubMed ID: 29440578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why put up with immunity when there is resistance: an excursion into the population and evolutionary dynamics of restriction-modification and CRISPR-Cas.
    Gurney J; Pleška M; Levin BR
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180096. PubMed ID: 30905282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CRISPR adaptive immunity systems of procaryotes].
    Mol Biol (Mosk); 2012; 46(2):195-203. PubMed ID: 22670515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The physicist's guide to one of biotechnology's hottest new topics: CRISPR-Cas.
    Bonomo ME; Deem MW
    Phys Biol; 2018 Apr; 15(4):041002. PubMed ID: 29543191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas Technologies and Applications in Food Bacteria.
    Stout E; Klaenhammer T; Barrangou R
    Annu Rev Food Sci Technol; 2017 Feb; 8():413-437. PubMed ID: 28245154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling and enhancing CRISPR systems.
    Shivram H; Cress BF; Knott GJ; Doudna JA
    Nat Chem Biol; 2021 Jan; 17(1):10-19. PubMed ID: 33328654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The population and evolutionary dynamics of phage and bacteria with CRISPR-mediated immunity.
    Levin BR; Moineau S; Bushman M; Barrangou R
    PLoS Genet; 2013; 9(3):e1003312. PubMed ID: 23516369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coevolution between bacterial CRISPR-Cas systems and their bacteriophages.
    Watson BNJ; Steens JA; Staals RHJ; Westra ER; van Houte S
    Cell Host Microbe; 2021 May; 29(5):715-725. PubMed ID: 33984274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unravelling the structural and mechanistic basis of CRISPR-Cas systems.
    van der Oost J; Westra ER; Jackson RN; Wiedenheft B
    Nat Rev Microbiol; 2014 Jul; 12(7):479-92. PubMed ID: 24909109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.